Possibilities of systemic therapy in elderly, frail, patients with comorbidities and poor performance status


DOI:  https://www.doi.org/10.31917/2403218

Elderly, frail patients, patients who have comorbidities or poor performance
status are usually ineligible to clinical trials. Considering this, there is lack of data
regarding systemic anticancer treatment in those groups of patients. In the article will be provided a comprehensive review of data and discussed possibilities of treatment for these cohorts of patients.